Skip to content

PINNACLE® DM RSA Study

Multi-Center, Non-Controlled, Prospective Radiostereometric Analysis of the PINNACLE® Dual Mobility Construct

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05357664
Acronym
PIN DM
Enrollment
11
Registered
2022-05-03
Start date
2022-10-06
Completion date
2023-02-09
Last updated
2024-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Degenerative Arthritis, Osteoarthritis, Revision Arthroplasty

Brief summary

The primary objective is to establish the mean superior cup migration of the PINNACLE® Dual Mobility Construct using model-based RSA over the first two years post-implantation. The primary endpoint is the mean vertical subsidence (Y translation, also known as superior cup migration) at 2 years as measured with RSA. Additionally, the data from this study will be compared to historical PINNACLE® data obtained in study DSJ\_2018\_02.

Interventions

DEVICETotal Hip Arthroplasty

Pinnacle acetabular shells used with PINNACLE DM Metal liner and BIMENTUM ALTRX PE liner with DePuy metal or ceramic heads and DePuy femoral prostheses

Pinnacle acetabular shells used with Pinnacle DM Metal liner and BIMENTUM ALTRX PE liner with DePuy metal or ceramic heads and DePuy femoral prostheses

Sponsors

DePuy Orthopaedics
Lead SponsorINDUSTRY

Study design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
21 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Individuals requiring primary THA for: 1. a severely painful and/or disabled joint (typically due to non-inflammatory degenerative joint disease). 2. failed previous hip surgery. 3. or dislocation risks. 2. Individuals who are able to speak, read and comprehend the informed patient consent document and willing and able to provide informed patient consent for participation in the study and have authorized the transfer of his/her information to DePuy Synthes. 3. Individuals who are willing and able to return for follow-up as specified by the study protocol. 4. Individuals who are a minimum age of 21 years at the time of consent. 5. Individuals who are willing and able to complete the Subject Hip Outcomes questionnaires as specified by the study protocol. \-

Exclusion criteria

1. Individuals have active local or systemic infection. 2. Individuals who have loss of musculature, neuromuscular compromise or vascular deficiency in the affected limb rendering the procedure unjustified. 3. Individuals with poor bone quality, such as osteoporosis, where in the surgeon's opinion, there could be considerable migration of the prosthesis or a significant chance of bone fracture and/or the lack of adequate bone to support the implant(s). 4. Individuals with Charcot's or Paget's disease. 5. Individuals who, in the judgement of the investigator, would not be a candidate for protocol allowable components to be used for their THA. 6. Women who are pregnant or lactating. 7. Individuals who have had a contralateral hip that was implanted less than 6 months prior to the time of consent into this study or individuals that expect to have a contralateral hip implanted in the 6 months following the time of consent into this study. 8. Individuals that have amputations in either leg that would impact rehabilitation following surgery. 9. Individuals who are bedridden per the Investigators determination 10. Individuals that have participated in a clinical investigation with an investigational product (drug or device) in the last three months. 11. Individuals currently involved in any personal injury litigation, medical-legal or worker's compensation claims. 12. Individuals, in the opinion of the Investigator, who are drug or alcohol abusers or have a psychological disorder that could affect their ability to complete patient reported questionnaires or be compliant with follow-up requirements. 13. Individuals diagnosed and taking prescription medications to treat a muscular disorder that limits mobility due to sever stiffness and pain such as fibromyalgia or polymyalgia. 14. Subject has a medical condition with less than 2 years life expectancy. 15. Individual has a BMI \>45 kg/m2. 16. Individuals who require revision arthroplasty and have a well-fixed non-DePuy Synthes femoral stem or a well-fixed DePuy Synthes femoral stem that does not have a polished neck

Design outcomes

Primary

MeasureTime frameDescription
Superior Cup Migration2 yearsRadiostereometric analysis (RSA) measured mean superior cup migration (Y translation in MM)

Secondary

MeasureTime frameDescription
HOOS Jr Score6 weeksHip Disability and Osteoarthritis Outcome Score, Joint Replacement (HOOS, JR) assesses patient pain (2 items), and functions of daily living (4 items). Scores range from 0 to 100 with a score of 0 indicating total hip disability and 100 indicating perfect hip health. This is a patient reported joint-specific score designed to evaluate outcomes after total hip arthroplasty
FJS-126 weeksThe Forgotten Joint Score (FJS-12) is a patient-reported outcome measure intended to determine a patient's ability to forget about their affected joint after surgery or treatment. The Forgotten Joint Score consists of 12 questions and is scored on a 0-100 scale. The higher the score, the less the patient is aware of their affected joint when performing daily activities which suggests a better outcome
Harris Hip Score6 weeks post operativeThe Harris Hip Score (HHS) has 10 items with four subscales comprising a minimum of 0 points and a maximum of 100 points with higher scores representing better function and outcomes. The four subscales include: pain severity, activities of daily living, absence of deformity and range of motion. Scoring is done according to the following: 90-100 = excellent, 80-89 = good, 70-79 = fair, 60-69 = poor, and below 60 is a failed result
RSA Measured Subsidence (Superior Cup Migration)3 months, 6 months and 1 yearSuperior migration of the acetabular cup will be measured using RSA
Additional RSA Measurements6 weeks, 3 months, 6 months, 1 year and 2 yearsAdditional RSA measurements (X and Z translations in mm, X, Y, and Z rotations in degrees, and maximal total point motion in mm) at all time points
Linear Head Penetration6 weeks, 1 year, 2 yearsFemoral head penetration into the polyethylene liner component will be determined and measured radiographically

Countries

Canada

Participant flow

Recruitment details

Patients were selected for recruitment into the study from the general diagnosis populations defined as primary total hip arthroplasty (THA) and revision total hip arthroplasty (RTHA). The investigation was conducted at two centers.

Participants by arm

ArmCount
PINNACLE Dual Mobility System
PINNACLE® Acetabular Cup, PINNACLE® CoCrMo Dual Mobility Metal Liner, a BI-MENTUM™ ALTRX® Dual Mobility Polyethylene Liner, a DePuy femoral stem with a polished femoral neck and a DePuy modular, femoral head PINNACLE® Dual Mobility Metal Liners and Porous-coated PINNACLE® Acetabular Cups are intended for cementless applications.
11
PINNACLE Dual Mobility System
PINNACLE® Acetabular Cup, PINNACLE® CoCrMo Dual Mobility Metal Liner, a BI-MENTUM™ ALTRX® Dual Mobility Polyethylene Liner, a DePuy femoral stem with a polished femoral neck and a DePuy modular, femoral head PINNACLE® Dual Mobility Metal Liners and Porous-coated PINNACLE® Acetabular Cups are intended for cementless applications.
11
Total22

Baseline characteristics

CharacteristicPINNACLE Dual Mobility System
Age, Continuous71.1 Years
STANDARD_DEVIATION 8.26
Body Mass Index (BMI)29.4 kg/m2
STANDARD_DEVIATION 6.5
Sex: Female, Male
Female
6 Participants
Sex: Female, Male
Male
5 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 11
other
Total, other adverse events
2 / 11
serious
Total, serious adverse events
1 / 11

Outcome results

Primary

Superior Cup Migration

Radiostereometric analysis (RSA) measured mean superior cup migration (Y translation in MM)

Time frame: 2 years

Population: Study subjects who reach two years follow-up will undergo radiostereometric analysis of the study hip to determine if the acetabular cup has migrated from its post-operative position. Please note: data is not reported because the study was terminated at 6 weeks, therefore 2-year radiostereometric analyses could not be performed.

Secondary

Additional RSA Measurements

Additional RSA measurements (X and Z translations in mm, X, Y, and Z rotations in degrees, and maximal total point motion in mm) at all time points

Time frame: 6 weeks, 3 months, 6 months, 1 year and 2 years

Population: Study subjects who received a PINNACLE Dual Mobility implant. Please note: data is not reported because radiostereometric analyses were scheduled to be performed once all subjects had completed their visit at each interval. Since only 11 subjects were enrolled, no RSA measurements were performed prior to study closure at 6-weeks.

Secondary

FJS-12

The Forgotten Joint Score (FJS-12) is a patient-reported outcome measure intended to determine a patient's ability to forget about their affected joint after surgery or treatment. The Forgotten Joint Score consists of 12 questions and is scored on a 0-100 scale. The higher the score, the less the patient is aware of their affected joint when performing daily activities which suggests a better outcome

Time frame: 6 weeks

Population: All study subjects who received a PINNACLE Dual Mobility Implant were evaluated using the FJS-12

ArmMeasureValue (MEAN)Dispersion
Superior Acetabular Cup MigrationFJS-1244.4 Units on a scaleStandard Deviation 26
Secondary

Harris Hip Score

The Harris Hip Score (HHS) has 10 items with four subscales comprising a minimum of 0 points and a maximum of 100 points with higher scores representing better function and outcomes. The four subscales include: pain severity, activities of daily living, absence of deformity and range of motion. Scoring is done according to the following: 90-100 = excellent, 80-89 = good, 70-79 = fair, 60-69 = poor, and below 60 is a failed result

Time frame: 6 weeks post operative

Population: All study subjects who received a PINNACLE Dual Mobility implant will have their operative hip assessed

ArmMeasureValue (MEAN)Dispersion
Superior Acetabular Cup MigrationHarris Hip Score79.7 units on a scaleStandard Deviation 9.63
Secondary

HOOS Jr Score

Hip Disability and Osteoarthritis Outcome Score, Joint Replacement (HOOS, JR) assesses patient pain (2 items), and functions of daily living (4 items). Scores range from 0 to 100 with a score of 0 indicating total hip disability and 100 indicating perfect hip health. This is a patient reported joint-specific score designed to evaluate outcomes after total hip arthroplasty

Time frame: 6 weeks

Population: All study subjects who received a PINNACLE Dual Mobility implant were evaluated using the HOOS Jr

ArmMeasureValue (MEAN)Dispersion
Superior Acetabular Cup MigrationHOOS Jr Score75.3 Units on a scaleStandard Deviation 10.29
Secondary

Linear Head Penetration

Femoral head penetration into the polyethylene liner component will be determined and measured radiographically

Time frame: 6 weeks, 1 year, 2 years

Population: Study subjects who received a Pinnacle Dual Mobility implant will have linear head penetration measured at specified timepoints. Please note: data is not reported because radiostereometric analyses were scheduled to be performed once all subjects had completed their visit at each interval. Since only 11 subjects were enrolled, no RSA measurements were performed prior to study closure at 6-weeks.

Secondary

RSA Measured Subsidence (Superior Cup Migration)

Superior migration of the acetabular cup will be measured using RSA

Time frame: 3 months, 6 months and 1 year

Population: Study subjects who received a PINNACLE Dual Mobility implant. Please note: data is not reported because radiostereometric analyses were scheduled to be performed once all subjects had completed their visit at each interval. Since only 11 subjects were enrolled, no RSA measurements were performed prior to study closure at 6-weeks.

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026